Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18559352 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity
Conditions: Obesity;   Laparoscopic Gastric Bypass Surgery;   Surgical Conditions;   Respiratory Function;   Cerebral Tissue Oxygenation
Interventions: Drug: deep neuromuscular blockade with rocuronium, reversal with sugammadex;   Drug: normal neuromuscular blockade reversal with rocuronium, reversal with neostigmine
2 Suspended Functional Respiratory Imaging After Neostigmine or Sugammadex
Condition: Respiratory-Gated Imaging Techniques
Interventions: Drug: Neostigmine;   Drug: Sugammadex;   Drug: Water for injection

Indicates status has not been verified in more than two years